Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-11-19

Clinical Trial Update: Reversal of Ventricular Remodeling With Toprol-XL [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating whether Toprol-XL (metoprolol succinate) reverses ventricular remodeling in heart failure; the study has been completed. The res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TOPROL XL (METOPROLOL SUCCINATE)

Snippet

Sponsor: AstraZeneca | Conditions: Heart Failure, Congestive | Phase 3 | Status: COMPLETED